Verrustat Wart Remover Liquid
NDC Package 44577-020-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Verrustat Wart Remover (salicylic acid) liquids is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a liquid delivery system. Marketed by Clinical Therapeutic Solutions, this product is identified by NDC 44577-020 and is authorized under FDA application M028.

Identification & Billing

NDC Package Code
44577-020-15
Package Description
1 BOTTLE, WITH APPLICATOR in 1 BOX / 15 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
44577-020
11-Digit Billing Format
44577002015
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Verrustat Wart Remover
Non-Proprietary Name
Salicylic Acid
Substance Name
Salicylic Acid
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
SALICYLIC ACID 170 mg/mL
Usage Information
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

Regulatory & Marketing

Labeler Name
Clinical Therapeutic Solutions
Product Type
Human Otc Drug
FDA Application #
M028
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-16-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 44577-020-15 identifies a specific commercial package of 1 bottle, with applicator in 1 box / 15 ml in 1 bottle, with applicator of Verrustat Wart Remover, a human over the counter drug labeled by Clinical Therapeutic Solutions. This liquid is formulated for topical use and contains salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Clinical Therapeutic Solutions on October 16, 2013. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

How is this Clinical Therapeutic Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 44577002015. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
44577-020-15
11-Digit CMS (5-4-2)
44577-0020-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.